Loading stock data…
$12.37+0.34 (+2.87%)
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally.
AngioDynamics, Inc. in the Healthcare sector is trading at $12.37 with a market capitalization of $627M. Wall Street consensus targets $19.75 (4 analysts), implying a +59.7% move over the next 12 months. The stock is currently 24% below its 52-week high of $16.29, remaining 0.4% below its 200-day moving average. On fundamentals, Piotroski 5/9 shows mixed financial quality. Risk note: RSI 28 is oversold, raising the odds of a near-term bounce. The Whystock Score of 60/100 suggests a balanced risk-reward profile.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $86.61M↑ | $78.42M↓ | $79.43M↑ | $75.71M↓ | $80.16M |
| Gross Profit | $46.77M↑ | $41.48M↓ | $44.78M↑ | $41.86M↓ | $42.22M |
| Operating Income | -$5.51M↑ | -$6.43M↓ | -$2.49M↑ | -$7.90M↓ | -$3.63M |
| Net Income | -$11.40M↓ | -$8.08M↓ | -$6.35M↑ | -$10.90M↓ | -$6.05M |
AngioDynamics, Inc., a medical technology company, designs, manufactures, and sells products for the treatment of cardiovascular disease and cancer diagnoses in the United States and internationally. The company operates through Med Tech and Med Devi...